Rheumatology - Rheumatology Xagena

Rheumatology

News

Drugs

Xagena Medicine

Xagena.net

The role of Type II Collagen in rheumatoid arthritis

Rheumatic disease increases risks in pregnancy

Rheumatoid arthritis, cannabis-based medicine relieves the pain and suppresses the disease

FDA approves Humira for first-line treatment of moderate to severe rheumatoid arthritis

Psoriatic arthritis, FDA approves Humira for reducing signs and symptoms of active arthritis

Scleroderma, Paclitaxel suppresses TGF-beta activity and reduces fibrotic tissue formation

Synthetic PLAD protein reduce arthritis symptoms in mice

Is rheumatoid arthritis becoming milder ?

Estrogen deprivation and joint pain

Brightly-coloured fruit and veg may protect against arthritis

Humira plus Methotrexate effective for long standing rheumatoid arthritis

Osteoarthritis of the knee, acupuncture offers short-term benefit

Certain types of exercise could protect against the risk of hip fracture

Doxycycline slows progression of knee osteoarthritis

Rheumatoid arthritis and osteoarthritis, role for Wnt-7b

Database studies may not accurately estimate risk of myocardial infarction in Naproxen, Ibuprofen users

Rheumatoid arthritis, gene therapy is safe and feasible

Rheumatoid arthritis, Rituximab improves symptoms in patients who failed DMARDs

Rituximab, a cancer drug, is effective in treating CNS lupus

Rheumatoid arthritis, early therapy with Adalimumab and Methotrexate may affect long-term disease progression

Rheumatoid arthritis, role of TNF on sex hormone production

Ankylosing spondylitis, benefits of continuous NSAID use

Anakinra in the treatment of children with juvenile arthritis

FDA approves Remicade for psoriatic arthritis

Dextromethorphan may help fibromyalgia patients

Synvisc: reported incidents of joint inflammation and pain

Rituximab improves symptoms in RA patients non-responders to anti-TNF therapies

FDA, changes to the class of non-steroidal anti-inflammatory drugs

Rheumatoid arthritis, TNF-alpha blockers may cause skin diseases

Parecoxib and Valdecoxib, increased cardiovascular events after CABG

Next Pages 1 [2] 3

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions